03:18 PM EDT, 10/31/2025 (MT Newswires) -- Pfizer ( PFE ) could leverage its White House connections to counter Novo Nordisk's ( NVO ) bid for obesity biotech company Metsera ( MTSR ) , Reuters reported Friday, citing analysts, investors and lawyers.

Pfizer ( PFE ) Chief Executive Albert Bourla has close ties to US President Donald Trump, and if there is any political influence, "Pfizer ( PFE ) is on the right side of that equation," Bernstein Analyst Courtney Breen stated, according to the media outlet.

On Thursday, Metsera ( MTSR ) said Novo Nordisk's ( NVO ) bid is "superior" to Pfizer's ( PFE ) offer and that the US drugmaker has four trading days to make a counteroffer.

When asked for comment by MT Newswires on Friday, Pfizer ( PFE ) referred its Thursday statement saying Novo Nordisk's ( NVO ) bid is "illusory and cannot qualify as a superior proposal under Pfizer's ( PFE ) agreement with Metsera ( MTSR )" and the company could explore legal routes to challenge the rival offer.

(Market Chatter news is derived from conversations with market professionals globally. This information is believed to be from reliable sources but may include rumor and speculation. Accuracy is not guaranteed.)

Price: 24.64, Change: +0.35, Percent Change: +1.44